Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 - Archive ouverte HAL Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2015

Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1

(1) , (2) , (3) , (4) , (5) , (2) , (6) , (7) , (6) , (8) , (9) , (10) , (11)
1
2
3
4
5
6
7
8
9
10
11
Nathalie Moiré
Stéphane Bach

Abstract

Using a structure-based design approach, we have developed a new series of imidazo[1,2-b]pyridazines, targeting the calcium-dependent protein kinase-1 (CDPK1) from Toxoplasma gondii. Twenty derivatives were thus synthesized. Structure-activity relationships and docking studies confirmed the binding mode of these inhibitors within the ATP binding pocket of TgCDPK1. Two lead compounds (16a and 16f) were then identified, which were able to block TgCDPK1 enzymatic activity at low nanomolar concentrations, with a good selectivity profile against a panel of mammalian kinases. The potential of these inhibitors was confirmed in vitro on T. gondii growth, with EC50 values of 100 nM and 70 nM, respectively. These best candidates also displayed low toxicity to mammalian cells and were selected for further in vivo investigations on murine model of acute toxoplasmosis.
Not file

Dates and versions

hal-02389861 , version 1 (02-12-2019)

Identifiers

Cite

Espérance Moine, Isabelle Dimier-Poisson, Cécile Enguehard-Gueiffier, Cédric Logé, Mélanie Pénichon, et al.. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1. European Journal of Medicinal Chemistry, 2015, 105, pp.80-105. ⟨10.1016/j.ejmech.2015.10.004⟩. ⟨hal-02389861⟩
108 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More